Giant Cell Arteritis: A Case-Based Narrative Review of the Literature

Davis C Thomas1, Prisly Thomas2, Deep P Pillai2

  • 1Center for TMD and Orofacial Pain, Rutgers School of Dental Medicine, Newark, NJ, USA. davisct1@gmail.com.

Insights

Giant cell arteritis (GCA), an inflammatory condition affecting large arteries, can cause headache and facial pain. Early diagnosis and treatment are crucial to prevent vision loss and other complications.

Area of Science:

  • Rheumatology
  • Neurology
  • Ophthalmology

Background:

  • Giant cell arteritis (GCA) is a chronic inflammatory vasculitis affecting medium and large arteries.
  • It commonly presents with symptoms such as headache and facial pain, potentially leading to serious complications.

Purpose of the Study:

  • To review Giant cell arteritis (GCA) in the context of headache and facial pain.
  • To highlight the importance of understanding GCA's etiology, pathophysiology, associated conditions, and differential diagnoses for effective management.

Main Methods:

  • This narrative review synthesizes information from a case presentation and current medical literature.
  • Focuses on clinical presentation, diagnostic considerations, and management strategies for GCA.

Main Results:

  • Giant cell arteritis (GCA) should be considered in patients with unilateral facial/head pain and visual disturbances.
  • GCA is associated with comorbid conditions, including COVID-19 infection.
  • Prompt identification of the affected artery and treatment are essential to prevent permanent visual loss and other complications.

Conclusions:

  • An interdisciplinary approach is strongly recommended for managing Giant cell arteritis (GCA).
  • Early recognition and intervention are critical to mitigate the severe consequences of GCA.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
27
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
32
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
34